Date: Monday 20 Apr 2009
UK-based GlaxoSmithKline was in late stage talks on Sunday to acquire Stiefel Laboratories, a US maker of skin care pharmaceuticals, for roughly $3bn, according to a source close to the matter, says the FT.
The CBI will today join the growing list of economists and business groups arguing...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news